drugset / Trial / NCT01438177
Chloroquine in Combination With VELCADE and Cyclophosphamide for Relapsed and Refractory Multiple Myeloma
NaSingle-groupOpen-labelTreatment
Summary
This pilot phase II trial studies how well giving bortezomib and cyclophosphamide together with chloroquine works in treating patients with relapsed or refractory multiple myeloma.
Timeline
- Start
- 2011-10
- Primary completion
- 2014-02
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bortezomib | Small molecule | 1.3 mg/m2 | Intravenous |
| Subject | Chloroquine | Small molecule | 500 mg | Oral |
| Subject | Cyclophosphamide | Other / unclassified | 50 mg | Oral |